Magenta Therapeutics, Inc.
MGTA
NASDAQ
Weiss Ratings | MGTA - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Rating | ||||
Reward Index | Unrated | |||
Risk Index | Unrated | |||
Risk Grade | U | |||
Reward Grade | U | |||
Rating Factors | MGTA - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Dividend Index | Unrated | |||
Growth Index | Unrated | |||
Efficiency Index | Unrated | |||
Solvency Index | Unrated | |||
Total Return Index | Unrated | |||
Volatility Index | Unrated | |||
Beta / Standard Deviation | MGTA - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Beta | 1.97 | |||
Price History | MGTA - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
7-Day Total Return | -- | |||
30-Day Total Return | -- | |||
60-Day Total Return | -- | |||
90-Day Total Return | -- | |||
Year to Date Total Return | -- | |||
1-Year Total Return | -- | |||
2-Year Total Return | -- | |||
3-Year Total Return | -- | |||
5-Year Total Return | -- | |||
52-Week High % Change | -- | |||
52-Week Low % Change | -- | |||
Price | MGTA - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
52-Week High Price | $30.72 | |||
52-Week Low Price | $5.14 | |||
52-Week Low Price (Date) | Dec 21, 2022 | |||
52-Week High Price (Date) | Sep 14, 2022 | |||
Valuation | MGTA - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Market Cap | -- | |||
Enterprise Value | -- | |||
Price/Earnings (TTM) | -- | |||
Earnings Per Share (TTM) | -18.23 | |||
Earnings Per Share Growth | -- | |||
Price/Earnings To Growth | -- | |||
Price/Sales (TTM) | -- | |||
Price/Book (Q) | 0.57 | |||
Enterprise Value/Revenue (TTM) | -- | |||
Price | -- | |||
Enterprise Value/EBITDA (TTM) | -- | |||
Enterprise Value/EBIT | -- | |||
Market Cap Category | -- | |||
Dividends and Shares | MGTA - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Shares Outstanding | 3.79M | |||
Dividend Yield | -- | |||
Div. Per Share (Most Recent) | -- | |||
Dividend Per Share (TTM) | -- | |||
Payout Ratio (TTM) | -- | |||
Dividend Per Share (Most Recent) | -- | |||
Company Info | MGTA - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Phone Number | 857 242 0170 | |||
Address | 100 Technology Square Cambridge, MA 02139 | |||
Website | www.magentatx.com | |||
Country | United States | |||
Year Founded | 2015 | |||
Profitability | MGTA - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Operating Margin (TTM) | -- | |||
Profit Margin | -- | |||
Management Effectiveness | MGTA - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Return on Assets | -28.83% | |||
Return on Equity | -- | |||
Income Statement | MGTA - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Revenue (TTM) | -- | |||
Total Revenue (TTM) | -- | |||
Revenue Per Share | -- | |||
Gross Profit (TTM) | -- | |||
EBITDA (TTM) | -57.18M | |||
EBIT (TTM) | -58.54M | |||
Net Income (TTM) | -68.70M | |||
Net Income Avl. to Common (TTM) | -68.70M | |||
Total Revenue Growth (Q YOY) | -- | |||
Earnings Growth (Q YOY) | 80.99% | |||
EPS Diluted (TTM) | -18.23 | |||
EPS Diluted Growth (Q YOY) | 81.57% | |||
Balance Sheet | MGTA - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Cash and Short-Term Inv. (Q) | 77.59M | |||
Cash Per Share (Q) | $20.47 | |||
Total Current Assets (Q) | 78.64M | |||
Total Preferred Equity (Q) | -- | |||
Total Equity (Q) | 74.60M | |||
Current Ratio (Q) | 19.494 | |||
Book Value Per Share (Q) | $19.77 | |||
Total Assets (Q) | 78.64M | |||
Total Current Liabilities (Q) | 4.03M | |||
Total Debt (Q) | 0.00 | |||
Total Liabilities (Q) | 4.03M | |||
Total Common Equity (Q) | 74.60M | |||
Cash Flow | MGTA - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Cash from Investing (TTM) | 75.83M | |||
Cash from Financing (TTM) | 2.83M | |||
Net Change in Cash (TTM) | 6.02M | |||
Levered Free Cash Flow (TTM) | -30.36M | |||
Cash from Operations (TTM) | -72.64M | |||